TV tonight: ‘Grey’s Anatomy,’ NCAA tournament starts – USA TODAY

Jesse Williams and Sarah Drew in ABC's 'Grey's Anatomy.'(Photo: Richard Cartwright, ABC)

NCAA Basketball Tournament CBS, 7 ET/4 PT

March Madness makes its 2017 primetime debut Thursday, taking over not just CBS, but TBS, TNT and TruTV. And if by some chance all that basketball isn't enough college athletics for you, the NCAA Wrestling Tournament is airing on ESPN. So theres pretty much something for everyone except, of course, for people who want to watch The Big Bang Theory and the rest of CBSs Thursday lineup, which is pre-empted.

USA TODAY

Ask our TV critic anything, get your answers on Facebook Live

Greys Anatomy ABC, 8 ET/PT

One fans blessing is another fans curse this week on Greys Anatomy. If you happen to be a fan of Jackson and April, youre in luck, as Thursdays episode is devoted to the sometimes couple, who travel to Montana to perform a complicated surgery on a young patient. And if youre not a fan? This would probably be a good week to explore other TV options.

Superstore NBC, 8 ET/PT

For example, if youre looking for something else to watch and you have fond memories of Ugly Betty, Superstore could be just the ticket, as its hosting a tiny Betty reunion. Tony Plana, who played Bettys dad, once again takes on a paternal role for America Ferrera, this time as Amys father. Turns out heneeds some help moving, and he gets it from Amy and Jonah.

Read or Share this story: http://usat.ly/2nuKwoS

Continued here:
TV tonight: 'Grey's Anatomy,' NCAA tournament starts - USA TODAY

From skin to brain: Stem cells without genetic modification – UB News Center

BUFFALO, N.Y. A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.

The applications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patients own cells.

Its actually quite remarkable that it happens, says Stelios T. Andreadis, PhD, professor and chair of UBs Department of Chemical and Biological Engineering, who recently published a paper on the results in the journal Stem Cells.

The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.

Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

In medical applications this has tremendous potential because you can always get a skin biopsy, Andreadis says. We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources.

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprograming to the pluripotent state.

The discovery was a gradual process, Andreadis says, as successive experiments kept leading to something new. It was one step at a time. It was a very challenging task that took almost five years and involved a wide range of expertise and collaborators to bring it to fruition, Andreadis says. Collaborators include Gabriella Popescu, PhD, professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Song Liu, PhD, vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UBs School of Public Health and Health Professions; and Marianne Bronner, PhD, professor of biology and biological engineering, California Institute of Technology.

Andreadis credits the persistence of his then-PhD student, Vivek K. Bajpai, for sticking with it.

He is an excellent and persistent student, Andreadis says. Most students would have given up. Andreadis also credits a seed grant from UBs office of the Vice President for Research and Economic Developments IMPACT program that enabled part of the work.

The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinsons-like symptoms in a mouse model of hypomyelinating disease.

This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further, Andreadis said.

The research, described in the journal Stem Cells under the title Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates, was supported by grants from the National Institutes of Health.

View post:
From skin to brain: Stem cells without genetic modification - UB News Center

Genetic Engineering Beyond Pesticides

Background

Genetic Engineering is an area that has gotten Beyond Pesticides attention in light of the pesticide paradigm that is being pushed in the form of genetically engineered food crops. Whether it is the incorporation into food crops of genes from a natural bacterium (Bt) or the development of a herbicide resistant crop, the approach to pest management is short sighted and dangerous.

Beyond Pesticides publicizes the serious health and pest resistance problems associated with the approach and provides important links to activists working in the pesticide community. Over 70% of all genetically modified organisms (GMOs) are altered to be herbicide-resistant. Increased planting of Herbicide-resistanat GE crops has led to a dramatic increase in herbicide use. The over use of Herbicide-resistant crops has also led to "super weeds", and the destructuion of pollinator habitat.

Our goal is to push for labeling as a means of identifying products that contain genetically engineered ingredients, seek to educate on the public health and environmental consequences of this technology, and generate support for sound ecological-based management systems. This technology should be subject to complete regulatory review, which is currently not the case.

As we move forward, we are united in opposing genetically engineered organisms in food production and believe that pressure to stop the proliferation of this contaminating technolgy must be focused on the White House and Congress. The companies responsible for this situation are the biotech companies whose GE technology causes genetic drift and environmental hazards that are not contained as the deregulation of genetically engineered alfalfa goes forward. The organic community stands together with consumer, farmer, environmental and business interests to ensure practices that are protective of health and the environment.

(August 1, 2016) President Signs Weak Product Labeling Law on Genetically Engineered Ingredients, Preempts States

(July 7, 2016) U.S. Senate Moves to Limit GMO Labeling

(April 20, 2016) GAO Finds USDA Regulation of Genetically Engineered Crops Deficient

(March 24, 2016) More Companies To Label for GE Ingredients, While Maintaining Their Safety

(March 21, 2016) Boulder County, Colorado to Phase Out GE Crops on Public Land

To read more, visit the GE section of our Daily News blog.

You can also find further information on the United States Department of Agriculture's website.

(2013 National Pesticide Forum)

As the emergent GE labeling movement challenges industrial agriculture, USDA continues to deregulate GE crops. This workshop was part of "Sustainable Families, Farms, and Food: Resilient communities through organic practices," Beyond Pesticides 31st National Pesticide Forum, April 5-6, 2013, Albuquerque, NM.

See the article here:
Genetic Engineering Beyond Pesticides

Biology Teacher Uses Science To Brilliantly Shut Down Transphobic Meme – A Plus

Fueled by Chicken Soup for the Soul

If you're going to use science to make a point, you'd better hope you know the science.

A meme circulating on Facebook caught the eye of Grace Pokela, a biology teacher at Arlington High School in Lagrangeville, New York. It didn't get her attention just for the poor science, but for the bigotry it was encouraging:

The meme began circulating around the same timethe Obama directive that allowed trans students in public schools to use the bathroom matching their gender identity was rescinded. When Pokela saw the post, she decided to make a Facebook status explaining why it was so off-base. Her response was such a thorough takedown of the meme that it was shared over 30,000 times.

Pokela started her post by explaining all the different variations of chromosomes we see in nature, and how they don't necessarily reflect or predict whether organisms are "male" or "female" terms that begin to seem much too simple to encapsulate the biological complexities of sex and gender as her post continues.

"You can be male because you were born female, but you have 5-alphareductase deficiency and so you grew a penis at age 12," she wrote. "You can be female because you have an X and a Y chromosome but you are insensitive to androgens, and so you have a female body. You can be female because you have an X and a Y chromosome but your Y is missing the SRY gene, and so you have a female body. You can be male because you have two X chromosomes, but one of your X's HAS an SRY gene, and so you have a male body. You can be male because you have two X chromosomes- but also a Y. You can be female because you have only one X chromosome at all. And you can be male because you have two X chromosomes, but your heart and brain are male."

Pokela drove her point home with poignant, incisive language. And she finished it with this kicker:

"Don't use science to justify your bigotry," Pokela wrote. "The world is way too weird for that shit."

Pokela's perspective is not unique in the scientific community, either. The American Medical Association, the American Psychiatric Association, and most other major medical organizations do not classify trans people as having a "psychological disorder" or a mental illness. In fact, as Pokela alluded to, there is a lot of evidence that supports the fact that trans people's experiences are underpinned by biological realities. For instance, the Journal of Clinical Endocrinology and Metabolism found that in trans women, the anatomy of the brain looks a lot more like a cisgender woman's brain than a cisgender man's.

"Facts have become so nebulous recently," Pokela said in an email to The Observer. "To see someone spouting such rage towards a truly oppressed group made me very upset. Using falsehoods to promote hate just rubbed me the wrong way."

View a related video below:

See the original post here:
Biology Teacher Uses Science To Brilliantly Shut Down Transphobic Meme - A Plus

Anorexia Nervosa Modeled in a Dish, Risk Gene Uncovered – Genetic Engineering & Biotechnology News

Although anorexia nervosa (AN) is often viewed as a nonbiological disorder, it is strongly suspected of having a genetic component, one that likely involves associations with multiple genes. These associations, however, appear to produce signals that are too faint to catch with the sort of genome-wide studies used thus far to evaluate AN. To enhance our sensitivity to AN's genetic signals, scientists based at the University of California San Diego School (UCSD) of Medicine have created a cellular model of the eating disorder. This model enabled the scientists to identify a gene, TACR1, that seems to contribute to AN pathophysiology.

The new findings appeared March 14 in the journal Translational Psychiatry, in an article entitled "Modeling Anorexia Nervosa: Transcriptional Insights from Human iPSC-Derived Neurons." The article notes that although AN has the highest mortality among psychiatric conditions, it still lacks robust and effective treatment, largely because the cellular and molecular mechanisms underlying the disease remain obscure.

In hopes of bringing these mechanisms to light, the UCSD team, led by Alysson Muotri, Ph.D., reprogrammed skin cells harvested from four females with AN and four healthy controls, induced these skin cells to become induced pluripotent stem cells (iPSCs), and differentiated the iPSCs into neurons.

The resulting neural cultures were "subjected to extensive transcriptome analysis," wrote the article's authors. "Within a small cohort of patients who presented for treatment, we identified a novel gene that appears to contribute to AN pathophysiology, TACR1 (tachykinin 1 receptor)."

The researchers explained that their unbiased comprehensive whole transcriptome and pathway analyses were arranged to determine not just which genes were being expressed or activated in AN neurons, but which genes or transcripts (bits of RNA used in cellular messaging) might be associated with causing or advancing the disease process.

Although the researchers failed to observe predicted differences in neurotransmitter levels, they did succeed in detecting the disruption of the TACR1 gene. This finding led the researchers to speculate that tachykinins might interact with other neurotransmitters to disrupt the tachykinin system and contribute to AN symptoms.

Tachykinins are neuropeptides or proteins expressed throughout the nervous and immune systems. These proteins participate in many cellular and physiological processes and have been linked to multiple diseases, including chronic inflammation, cancer, infection, and affective and addictive disorders.

"Although TACR1 has been associated with psychiatric conditions, especially anxiety disorders, we believe this report is its first association with AN," the authors of the Translational Psychiatry article concluded. "Moreover, our human iPSC approach is a proof-of-concept that AN can be modeled in vitro with a full human genetic complement, and represents a new tool for understanding the elusive molecular and cellular mechanisms underlying the disease."

"Anorexia is a very complicated, multifactorial neurodevelopmental disorder," commented Dr. Muotri. "It has proved to be a very difficult disease to study, let alone treat. We don't actually have good experimental models for eating disorders. In fact, there are no treatments to reverse AN symptoms.

"[Our work is] a novel technological advance in the field of eating disorders, which impacts millions of people. These findings transform our ability to study how genetic variations alter brain molecular pathways and cellular networks to change risk of ANand perhaps our ability to create new therapies."

The rest is here:
Anorexia Nervosa Modeled in a Dish, Risk Gene Uncovered - Genetic Engineering & Biotechnology News

Gene Expression’s Big Rethink – Genetic Engineering & Biotechnology News

Genetic Variation and Drug Response

Imagine taking a patients skin cells, using them to derive induced pluripotent stem cells [iPSCs], differentiating the stem cells to produce cells of a particular type, and then exposing the differentiated cells to drugs that the patient might be given, suggests Russ B. Altman, M.D., Ph.D., professor of bioengineering, genetics, medicine, and biomedical data science at Stanford University. Such procedures might detect the potential for drug-induced toxicity and reduce the incidence of serious side-effects in the clinical setting.

The ability to predict adverse effects is particularly important for therapeutic agents that are associated with a high likelihood of failure or adverse effects. Predicting adverse effects could also help tailor treatments in a more rational manner.

An example of a drug with a challenging adverse effect profile is doxorubicin. This chemotherapeutic agent is known to be cardiotoxic in some patients, but predicting which patients are at risk is difficult. In fact, no reliable means of predicting doxorubicin-induced cardiotoxicity (DIC) exists, so the drug cannot be administered with confidence.

In a recent study conducted in collaboration with Dr. Paul Burridge from Northwestern University School of Medicine and Dr. Joseph Wu from Stanford Cardiovascular Institute, and other colleagues, bioinformatics analyses performed by Dr. Altmans group were critical to show that patient-specific human induced pluripotent stem cell-derived cardiomyocytes can recapitulate at the single-cell level the predilection to develop doxorubicin-induced cardiotoxicity.

It was pretty straightforward, on the informatics side, to show a correlation between the cellular responses and the clinical responses, asserts Dr. Altman. This correlation is incredibly exciting.

Human iPSCs obtained from female patients with breast cancer and matched with healthy volunteers were differentiated into cardiomyocytes. RNA-Seq and microarray analyses were subsequently used to profile and compare gene-expression changes in the cardiomyocytes derived from the healthy volunteers and in those from the breast cancer patients with and without clinical DIC. Cells derived from patients presenting clinical DIC were more sensitive to therapy, exhibited increased metabolic stress and reactive oxygen species, and had impaired intracellular calcium signaling, as compared to cells derived from patients who did not show clinical DIC.

Using microarray analyses to examine gene-expression perturbations in response to various doxorubicin concentrations, this study revealed that in vitro, the cardiomyocytes recapitulated patients predilection to DIC. The study also indicated that genetic and molecular analyses could provide a powerful tool to predict clinical toxicity to therapeutic agents.

The findings in the research setting are very intriguing, comments Dr. Altman. There is a lot of engineering to make them more reliable and reproducible.

Even though stem cell studies have shown a lot of promise, reproducibility has been particularly challenging, and results from different labs may vary depending on multiple factors, including small differences in experimental protocols and the versions of the stem cells used by various labs, for which it is very difficult to show equivalency.

The work is only half complete when the research is published, Dr. Altman concludes. Lots of details need to be addressed before this can be put into routine clinical use.

Here is the original post:
Gene Expression's Big Rethink - Genetic Engineering & Biotechnology News

Partnerships: The key to getting green chemistry tech to market? – GreenBiz

Bringing greener chemicals, materials and process technologies to market and scale is not for the meek.

The complexity of the chemical supply chain requires development and commercialization partnerships for new technologies to become optimized, scaled and pulled into products and onto store shelves. This is especially true for chemistry startups that lack production facilities and established supply chain relationships built over time.

For the last 12 years, the Green Chemistry & Commerce Council (GC3) a cross-sector, business-to-business network of over 100 leading companies and other organizations has been bringing together a diverse group of companies across sectors and supply chains to collaborate on projects to accelerate green chemistry innovation.

Especially in recent years, we have noticed an exciting trend. Many new, innovative green and bio-based chemistry startups, led by energetic, highly trained and mission-driven entrepreneurs, are developing new chemical ingredients, materials and technologies.

These breakthroughs enable improved performance, fill critical technology gaps and replace problematic incumbent technologies such as perfluorinated water and stain repellants and brominated flame retardants. These startups are increasingly critical engines of innovation for green chemistry solutions, particularly as some larger chemical companies downsize their R&D.

For early stage technologies, scaling can be a substantial barrier.

To support the growth of these startups, in 2016 the GC3 launched the GC3 Green & Bio-based Chemistry Startup Network to leverage our broad membership and create an "innovation ecosystem" that connects startups with established chemical suppliers, brands, retailers and investors who can serve as strategic development and commercialization partners.

For large companies, the startups bring to the table the opportunity to expand into new, strategic technology areas and can bring in a little startup culture and fresh ideas. For startups, partnering with a larger company can provide market recognition, technology and application improvements, plus access to broader market distribution and scale.

To explore challenges faced in partnering on both sides of the table and factors that can increase the chances of success, in February the GC3 organized a one-day workshop, "Leveraging Partnerships to Accelerate Green & Bio-based Chemistry Innovation" (PDF), hosted by Levi Strauss & Co at their Global Headquarters in San Francisco.

The workshop brought together 26 startup companies developing green and bio-based technologies pursuing technologies such asrenewable specialty chemicals, high-performance recyclable plastics and safer methods for bleaching fabrics. In addition, 20 more established companies participated, from chemical and material suppliers such as 3M, Covestro and Dow to brands and retailers such as Apple, Method, Patagonia and Target. Venture capital firms such as First Green Partners and Safer Made also attended.

During the workshop, we heard from startups about the importance of getting an established strategic partner on board early to build credibility and demonstrate the value of their technology to the broader market.

Stacy Flynn, CEO and co-founder of Evrnu, a startup textile technology company that creates recycled fiber from post-consumer garment waste, spoke about Evrnu's partnership with Levi Strauss & Co. to make a pair of the iconic 511 jeans.

"Getting Levis on board early was key to demonstrating belief in our technology," said Flynn.

While their partnership is still in an early stage, it has generated a lot of excitement about the possibilities of this new technology, which was made clear by the enthusiasm in the room when Flynn held up a pair of Levis jeans made with Evrnus fiber.

Many elements contribute to a successful partnership and they all depend on the technology and specific parties involved. However, from discussions throughout the day several core themes emerged:

Brands and retailers at the end of the value chain have a unique opportunity to provide the market pull needed to get green technologies to scale faster. By communicating to their suppliers and manufacturing partners further up the value chain that they are actively seeking greener ingredients and technologies, they can have a big impact.

For early stage technologies, scaling can be a substantial barrier. However, many larger companies in the room said that if they believe a technology is truly transformative, they would much rather encourage other companies, even competitors, to adopt the new technology to achieve success and scale than maintain exclusivity.

If its good for the world, we should share it.

"As companies, we have a huge opportunity to drive meaningful, systemic change by sharing innovations and programs with the industry," said Una Murphy, senior designer, product innovation at Levi Strauss & Co. "By bringing others along, we can achieve a much greater impact than we would by keeping information within our four walls."

Kaj Johnson, senior director, product development from People Against Dirty (aka Method Home and Ecover), echoed that sentiment: "If its good for the world, we should share it. We are a relatively small player and getting scale for new ingredients helps us. Why would I want exclusivity?"

The GC3 is expanding the network to include more startups and is creating new opportunities for networking and collaborative projects designed to get good technologies to market. Next up is the Green & Bio-Based Chemistry Technology Showcase & Networking Event, hosted by Steelcase on April 24, where big brands and retailers will do reverse pitches, presenting their strategic technology needs to the startups, and 10 invited startups will present on their innovative green technologies.

For more information on the GC3 Startup Network, contact the GC3.

Go here to read the rest:
Partnerships: The key to getting green chemistry tech to market? - GreenBiz

Chemistry Club to host ‘Star Wars’ theme demo night – NIU Today

On March 31 at a University not so far away Chem Wars!

NIUs Chemistry Club invites the public to its annual Spring Chemistry Demo Night on Friday, March 31, at 6:30 p.m. in Cole Hall room 100.

This year, the Chemistry Club will put on Chem Wars, a show which will feature a number of thrilling experiments that could have been used by the big film studios in Hollywood to create the special effects in the science fiction franchises we all love and cherish.

We certainly hope that the Star Wars theme draws lots of people to come to the show. However, I am confident that when they leave they will not only better understand the chemical concepts behind these experiments but also appreciate the love of chemistry that all volunteers participating in the show share, Chemistry Club President Marina Galluzzo says.

Faculty members helping with this years demo include Tim Hagen, Lee Sunderlin, Chong Zheng, Tim Perkins and the Chemistry Clubs faculty advisor, Oliver Hofstetter.

The annual Chem Demo really is the highlight of the year when it comes to presenting ourselves and reaching out to the community. It is an exciting opportunity to demonstrate that science is fun and that scientists are just people like you and me, Hofstetter explains.

While the night will include some crowd favorites from previous years, such as the liquid nitrogen bomb and ping-pong madness, the Chem Club will also serve freshly prepared ice cream at the end of the performance.

The force will be strong with this one. Just ask Chemistry Club Demo co-coordinator, Devon Boland. After having participated in several chemistry demos over the last couple of years, I can assure you that this years show will be one for the ages: We have Star Wars, rivalries and most importantly lightsabers! This is an event you dont want to miss! I bet that all ages will leave laughing, cheering and being excited. So, make sure you come, feel free to put on your favorite costume be it from Star Wars, Star Trek or whatever. Join us for one spectacular show!

Expect bright flashes of light and intermittent periods of low light and/or darkness during the event.

Free parking will be available in the NIU Parking Deck starting at 5 p.m., except for reserved and handicapped spaces.

For more information about the Chemistry Demo, please, contact Marina Galluzzo at mgalluzzo@niu.edu.

For more information about the Chemistry Club, contact Dr. Hofstetter at ohofst@niu.edu.

Read more here:
Chemistry Club to host 'Star Wars' theme demo night - NIU Today

Solid core: Davie softball coach says chemistry is better this year – Winston-Salem Journal

It was heartbreaking the way we ended it last year because we obviously wanted to win states last year. This year, weve come focused, prepared, and have been working very hard in practice.Olivia Boger Senior pitcher

The Davie County softball team started the season with high expectations after a deep run in last seasons NCHSAA Class 4-A playoffs.

So with five seniors returning from a team that advanced to the region semifinals in the NCHSAA Class 4-A playoffs, Davie County could push defending state champion West Forsyth, North Davidson and possibly Reagan for the conference title.

In my mind, we always have a chance to win it, coach Dawn Lowery of Davie County said. Again, it all boils down to the leadership on your team, and I think the leadership on our team is solid. Our chemistry is better this year than it has been.

I think that the girls are playing well together and they trust each other.

Much of the leadership comes from the War Eagles five seniors pitcher Olivia Boger (committed to Mercer), third baseman Klea Parks (North Greenville), Kenzie Smith (Appalachian State), Jessie Beck (Guilford) and McKenzie Barneycastle (Newberry). That group is confident the War Eagles will rebound and have a successful season.

It was heartbreaking the way we ended it last year because we obviously wanted to win states last year, Boger said. This year, weve come focused, prepared, and have been working very hard in practice.

Barneycastle isnt playing because she had a benign tumor removed from her cerebellum.

She had brain surgery on Monday, and shes been out. They found it in November, Lowery said. They had scheduled her like the first week of the season, and then she got the flu. They had to push it back two weeks.

Lowery said the tumor was not cancerous at the time of the operation and the surgery was cautionary.

They did a biopsy. I dont know all of the details, but it had a greater chance of becoming cancerous, Lowery said. So they went ahead and removed it.

According to Lowery, Barneycastle is at home resting and would be out an average of six weeks. However, it could be more or less depending on how she recovers. There is even a chance she could play toward the end of season and the playoffs.

If its up to Barney, she will, Lowery said. Shes a fighter, man. Its an unfortunate situation for a senior, but shes tough and shes handling it with great maturity. And she wants to be out here. I know shes going to do everything in her power to be out here, but obviously her health is most important.

Parks said the War Eagles have dedicated the season to Barneycastle.

Barney, shes our girl, Parks said. Even though shes going through this tough time right now its all for her. Everything we do is for her.

Davie has a tough schedule, and it showed last Tuesday after being throttled 10-0 by Class 2-A power Forbush. Davie won 15-0 at home against Reagan on Friday night and played at West Forsyth Tuesday night.

Games like (Forbush), you just cant let it linger over your head, Lowery said. You cant let it defeat you for the next three or four games. Youve just got to learn from it. Ive always believed in us, and I think the girls are finally starting to believe in it too.

Davie also plays host to North Davidson on Friday, is at Mount Tabor on March 20 and has a home game March 22 against Glenn.

These preseason games have done us well to prepare us, Boger said. Weve got a really tough schedule this year, and weve played really tough teams to prepare us for the state playoffs. I really feel like were going to be prepared.

Expectations are one thing, but following through and being successful with a chance at competing for a Class 4-A state title is another.

We kind of all agree that were going to take it one game at a time, one inning at a time, one pitch at a time because thats probably how were going to be the most successful, Smith said.

Boger said playing tough teams in the conference almost every night is a challenge and makes it fun.

I think its amazing, Smith said. Its really cool because it really tests your limits. And for those of us who are going to play college ball its even better. It really shows you no matter how hard you think youre working, everyone else is working just as hard. So it kind of teaches you life lessons.

Beck, a utility player, said the loss to Forbush can make Davie better.

It was a loss, but we got it out of our way, Beck said. So now were ready to go.

Beck feels that Davie can compete for a conference title, but like Smith, she said its one game at a time.

We prepare the same way for every team, Beck said. We dont take any team lighter than any other team, so weve basically been preparing for these games our whole season, our whole career.

The regular season doesnt conclude until Davie plays host to Parkland on April 28. The following week is the conference tournament and the state tournament begins May 10.

The talents there, Lowery said. Weve just got to make it all come together at the right time.

See the original post here:
Solid core: Davie softball coach says chemistry is better this year - Winston-Salem Journal

Pain in the neck: Engineers use CRISPR technology to prevent … – Science Daily

For millions of sufferers, there is nothing more debilitating than chronic back or joint pain. It can feel like a lifetime of misery.

But researchers led by University of Utah bioengineering assistant professor Robby Bowles have discovered a way to curb chronic pain by modulating genes that reduce tissue- and cell-damaging inflammation.

"This has applications for many inflammatory-driven diseases," Bowles says. "It could be applied for arthritis or to therapeutic cells that are being delivered to inflammatory environments that need to be protected from inflammation."

The team's discovery was published in a new paper this month, "CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments," in a special issue of Tissue Engineering. University of Utah bioengineering doctoral student, Niloofar Farhang, co-authored the study, which is a collaborative project between the University of Utah, Duke University and Washington University in St. Louis.

In chronic back pain, for example, slipped or herniated discs are a result of damaged tissue when inflammation causes cells to create molecules that break down tissue. Typically, inflammation is nature's way of alerting the immune system to repair tissue or tackle infection. But chronic inflammation can instead lead to tissue degeneration and pain.

Bowles' team is using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) system -- new technology of modifying human genetics -- to stop cell death and keep the cells from producing molecules that damage tissue and result in chronic pain. But it doesn't do this by editing or replacing genes, which is what CRISPR tools are typically used for. Instead, it modulates the way genes turn on and off in order to protect cells from inflammation and thus breaking down tissue.

"So they won't respond to inflammation. It disrupts this chronic inflammation pattern that leads to tissue degeneration and pain," Bowles says. "We're not changing what is in your genetic code. We're altering what is expressed. Normally, cells do this themselves, but we are taking engineering control over these cells to tell them what to turn on and turn off."

Now that researchers know they can do this, doctors will be able to modify the genes via an injection directly to the affected area and delay the degeneration of tissue. In the case of back pain, a patient may get a discectomy to remove part of a herniated disc to relieve the pain, but tissue near the spinal cord may continue to breakdown, leading to future pain. This method could stave off additional surgeries by stopping the tissue damage.

"The hope is that this stops degeneration in its tracks, and the patient could avoid any future surgeries," Bowles says. "But it's patient to patient. Some might still need surgery, but it could delay it."

So far, the team has developed a virus that can deliver the gene therapy and has filed a patent on the system. They hope to proceed to human trials after collecting initial data, but Bowles believes it could be about 10 years before this method is used in patients.

Story Source:

Materials provided by University of Utah. Note: Content may be edited for style and length.

Follow this link:
Pain in the neck: Engineers use CRISPR technology to prevent ... - Science Daily

U. scientists develop cell therapy for chronic disc pain – Deseret News

SALT LAKE CITY Relief for chronic back and neck pain may be on the horizon, thanks to emerging science technology under development at the University of Utah.

Bioengineering researchers have discovered a technique to control chronic pain by regulating genes that reduce tissue- and cell-damaging inflammation.

This has applications for many inflammatory-driven diseases, said assistant professor Robby Bowles, who led the research. It could be applied for arthritis or to therapeutic cells that are being delivered to inflammatory environments that need to be protected from inflammation.

In laymens terms, the therapy has the potential to treat chronic pain by relieving swelling in affected areas and healing the tissue, he said.

For instance, chronic pain in slipped or herniated discs result from damaged tissue when swelling causes cells to create molecules that break down tissue, he explained. Inflammation is natures way of alerting the immune system to repair tissue or fight infection, but chronic inflammation can lead to tissue degeneration and pain, he said.

Bowles team uses the Clustered Regularly Interspaced Short Palindromic Repeat system known as CRISPR a new technology that modifies human genetics to halt cell death and keep cells from producing molecules that damage tissue and result in chronic pain, he said.

This is something that could be injected into your (damaged) discs to stop the signaling that is driving disc degeneration and the painful signaling, Bowles said. It would keep you from getting worse and it would stop the pain.

But Bowles said the therapy does not edit or replace genes, which is what CRISPR tools are typically used for. Instead, the therapy modulates the way genes turn on and off in order to protect cells from inflammation.

So they wont respond to inflammation. It disrupts this chronic inflammation pattern that leads to tissue degeneration and pain, he said. Were not changing what is in your genetic code. Were altering what is expressed. Normally, cells do this themselves, but we are taking engineering control over these cells to tell them what to turn on and turn off.

He said now that researchers know they can do this, doctors would be able to modify the genes using direct injection into the affected area which delays tissue degeneration. In the case of back pain, a patient may get a discectomy to remove part of a herniated disc to relieve the pain, but tissue near the spinal cord may continue to break down, leading to future pain, he said. This method could stave off additional surgeries by stopping the tissue damage, he noted.

The hope is that this stops degeneration in its tracks, and the patient could avoid any future surgeries, Bowles said. But its patient to patient. Some might still need surgery, but it could delay it.

So far, the team has developed a virus that can deliver the gene therapy and has filed for a patent on the system with the hope of moving to human trials after collecting initial data. One caveat Bowles noted was that there are currently no gene therapies approved for use by the U.S. Food and Drug Administration, so it may take some time to receive necessary acceptance.

So long term there are technological and regulatory hurdles to (overcome), he said. It could be about 10 years before this method is ready for use in patients.

Despite the regulatory issues, Bowles was optimistic about the long-range prospects for treating pain using this new therapy.

The CRISPR systems give us control that would allow us to begin treating these diseases in ways we couldnt treat them before, Bowles said. Over the next 10 to 15 years, were going to see a lot of these CRISPR technologies change these debilitating conditions.

The teams discovery was published in a new paper this month in a special issue of Tissue Engineering. The study was co-authored by University of Utah bioengineering doctoral student Niloofar Farhang and several other researchers in a collaborative project between the U., Duke University and Washington University in St. Louis.

Go here to read the rest:
U. scientists develop cell therapy for chronic disc pain - Deseret News

Anatomy – Tips and Advice for Studying

What Is Anatomy?

Anatomy is the study of the structure of living organisms. This subdiscipline of biology can be further categorized into the study of large scale anatomical structures (gross anatomy) and the study of microscopic anatomical structures (microscopic anatomy). Human anatomy deals with anatomical structures of the human body, including cells, tissues, organs, and organ systems. Anatomy is always linked to physiology, the study of how biological processes function in living organisms.

Therefore it is not enough to be able to identify a structure, its function must also be understood.

The study of human anatomy gives us a better understanding of the structures of the body and how they work. When taking a basic anatomy course, your goal should be to learn and understand the structures and functions of the major body systems. It is important to remember that organ systems don't just exist as individual units. Each system depends on the others, either directly or indirectly, to keep the body functioning normally. It is also important to be able to identify the major cells, tissues, and organs being studied and to know how they function.

Studying anatomy involves lots of memorization. For instance, the human body contains 206 bones and over 600 muscles. Learning these structures requires time, effort, and good memorization skills. The following tips will help make learning and memorizing body structures easier.

The most important thing to understand when studying anatomy is the terminology. Using standard anatomical terminology ensures that anatomists have a common method of communicating to avoid confusion when identifying structures. Knowing anatomical directional terms and body planes for instance, enables you to describe the locations of structures in relation to other structures or locations in the body. Learning the common prefixes and suffixes used in anatomy and biology is also helpful. For example, if you are studying the brachiocephalic artery, you can figure out its function by knowing the affixes in the name. The affix brachio- refers to the upper arm and cephal refers to the head. If you have memorized that an artery is a blood vessel that carries blood away from the heart, you can determine that the brachiocephalic artery is a blood vessel that carries blood from the heart to the head and arm regions of the body.

Study aids are very useful when studying anatomy. Believe it or not, anatomy coloring books are one of the best ways to learn and memorize structures and their location. The Anatomy Coloring Book is a popular choice, but other coloring books work as well. Anatomy flash cards, like Netter's Anatomy Flash Cards and Mosby's Anatomy & Physiology Study and Review Cards are recommended as well. Flash cards are valuable for reviewing information and are not meant to be a substitute for anatomy texts. Acquiring a good complementary text, such as Netter's Atlas of Human Anatomy, is a must for higher level anatomy courses and those interested in or already attending medical school. These resources provide detailed illustrations and pictures of various anatomical structures.

I can't state it enough, to really make sure you comprehend the material, you must constantly review what you have learned. It is vital that you attend any and all anatomy review sessions given by your instructor. Be sure to always take practice quizzes before taking any test or quiz. Get together with a study group and quiz each other on the material. If you are taking an anatomy course with a lab, be sure that you prepare for what you are going to be studying before lab class. The main thing you want to avoid is falling behind. With the volume of information that is covered in most anatomy courses, it is important that you stay ahead and know what you need to know, before you need to know it.

Organisms are arranged in a hierarchical structure. Cells compose tissues of the body, which can be categorized into four primary types. These tissue types are epithelial tissue, muscle tissue, connective tissue, and nervous tissue. Tissues in turn form organs of the body. Examples of body organs include the brain, heart, kidneys, lungs, liver, pancreas, thymus, and thyroid. Organ systems are formed from groups of organs and tissues working in conjunction to perform necessary functions for the survival of the organism. Examples of organ systems include the circulatory system, digestive system, endocrine system, nervous system, lymphatic system, skeletal system, and reproductive system.

More:
Anatomy - Tips and Advice for Studying

Grey’s Anatomy’s Big "Japril" Episode Just Might Be an Avery Family Reunion in Disguise – E! Online

For as long as he's been in our lives on Grey's Anatomy, Jackson Avery's father has never been in the picture.

We've gotten more than our fill of his mother, the domineering and ultra-successful Catherine Avery (Debbie Allen)especially with the mess she's created at Grey Sloan Memorial this year with the whole Minnick debaclebut we've never met the man who ran off when Jackson (Jesse Williams) was young, leavinghim to be raised by a single mother. But it looks like that all might be changingand soon.

In this sneak peek of Thursday's new episode, exclusive to E! News, Jackson and April (Sarah Drew) have traveled to Montana to treat a young patient, but when his ex-wife catches wise to what really may have brought them out to Big Sky Country, she's none too pleased.

"When are you gonna tell me that you found your father?" she unloads on her former spouse. "Your father, Jackson. Your long-lost deadbeat dad. The distinguished hippie former surgeon Dr. Avery who slings hash at the local diner. He's the whole reason we're here!"

"No, I came here to help a patient," Jackson replies, rather unconvincingly. Come on, Jackson! You're going to have to lie a little better than that.

The special episode, in which Williams and Drew are the only two series regulars to appear, is a sequel of sorts to the special season 12 episode that chronicled the pair's complete relationship history as they sign divorce papers amid April's secret secondpregnancy. Could what fans are affectionately referring to as "Japril: The Sequel" be the episode to bring these until as-of-late (thanks to Grey Sloan Memorial's ridiculous civil war) happy co-parents back together for good?

While the pair aren't spilling that precious detail under fear of retribution from their boss Shonda Rhimes, they did open up to E! News' Kristin Dos Santos about the episode."The relationshipWill they? Won't they? Are they going to stay together? They're co-parenting, being divorced, but living together. They can kind of escape through their work, but on this trip and in this episode, they're together," Williams teased during the recent TCA Winter Press Tour . "They have to face each other."

Are the actors themselves rooting for a reconciliation between their characters?"Yes, always. I'm just always rooting for them to get back together because they're great and I can't understand," Drew admitted. "There was stuff that made sense for them to be apart, but now it feels like that's in the pastJapril forever!"

Are you still holding out hope for Japril to get their act together and reconcile? Sound off in the comments below!

Grey's Anatomy airs Thursdays at 8 p.m. on ABC.

E! Online - Your source for entertainment news, celebrities, celeb news, and celebrity gossip. Check out the hottest fashion, photos, movies and TV shows!

Read the original:
Grey's Anatomy's Big "Japril" Episode Just Might Be an Avery Family Reunion in Disguise - E! Online

The anatomy of Philip Hammond’s U-turn over National Insurance – iNews

It took the government just under a week to announce its dramatic U-turn over National Insurance rates.

How the policy the centrepiece of the Budget unravelled:

1.15, 8 March: Philip Hammond announces increase in National Insurance rates for around 2.5m self-employed people.

1.30: In a chaotic post-Budget briefing, Treasury aides deny the tax hike breached the Tory manifesto promise. Mr Hammonds spokeswoman argues that the policy had been fleshed out in a taxation Bill published two months after the election.

9 March: Newspaper headlines about the policy are universally damning.

Conservative backbench protests mount against the move. By the end of the day, 20 have been openly critical.

A Welsh Office minister, Guto Bebb, says the government should say sorry for the policy.

Theresa May, speaking in Brussels, insists the policy would make the tax system simpler, fairer and more progressive. But she promises to delay it until the autumn following further consultation.

10 March: Footage emerges of David Cameron apparently describing as stupid the decision to break the manifesto promise.

11 March: Ex-Chancellor Norman Lamont mocked by Mr Hammond in his Budget speech attacks the rookie error.

12 March: Sunday newspapers carry lurid accounts of recriminations between Downing Street and the Treasury over the NI decision.

14 March: Business minister Margot James lets slip that the policy is under review, saying the increase had simply been mooted.

Morning, 15 March: Theresa May and Philip Hammond meet in Downing Street and agree to abandon the planned rise.

11.32: Minister Rory Stewart defends the rise on BBC1s Daily Politics.

11.37: U-turn announced in letter from Mr Hammond to Tory MPs.

12.02: At the beginning of Prime Ministers Questions, Theresa May confirms that the planned increases have been scrapped.

Originally posted here:
The anatomy of Philip Hammond's U-turn over National Insurance - iNews

Poulter explains the anatomy of a shank, and why they happen to him so often – Golf.com

Why do shanks happen to Ian Poulter so often? Let him explain.

Getty Images

Ian Poulter, admittedly, has hit his fair share of shanks while on the PGA and European tours, but he has an explanation for them.

Poulter joined Sports Illustrated's Alan Shipnuck for a lengthy podcast at Poulter's Florida home on Monday. They discussed a handful of topics from the Ryder Cup to his social media use to the closing of his company and, of course, the fact that he hits more hosel-rockets than most pros.

"There's obviously a fault in my swing, where I dip slightly into my swing on given times," Poulter said. "Now, if you look at the wear spots on all of my old sets of irons in this room, you will see they are all very close to the heel. Some players have it slightly toe-orientated, some player have it out in the middle, some players have it on the heel. With having that sweet spot close to the heel brings your chance of a shank, obviously, a lot higher percentage than someone who has a wear spot at the toe. Now especially if you are going to move slightly forward into the shot; it's going to happen."

And do they make him mad? Of course they do.

"You just laugh it off," he said. "It really pisses me off. It really, really pisses me off. It's been hard at times, because it's happened at the wrong time. Honda, par-3, 5th hole, bad timing. I was going to play a soft shot, and at the time, I went through a little period where I was hitting these little three-quarter soft shots, and that happened a couple of times. Had the yardage been slightly different I may not have been in that situation where I would have hit a shank. But it did, and it happens."

As Shipnuck points out, Poulter, to his credit, has been remarkably good at saving par after many of his shanks. And the 41-year-old pro has great advice for any amateur who has a case of the shanks as well.

"It's not that bad a shot, is it?" he said. "I mean, it is bad; the result's bad, but the actual swing itself was about a half inch from perfection."

You can listen to the complete podcast below.

Read more:
Poulter explains the anatomy of a shank, and why they happen to him so often - Golf.com

A Revolutionary Genetic Experiment is Planned for a West African Village If Residents Agree – Scientific American

BANA, Burkina Faso This small village of mud-brick homes in West Africa might seem the least likely place for an experiment at the frontier of biology.

Yet scientists here are engaged in what could be the most promising, and perhaps one of the most frightening, biological experiments of our time. They are preparing for the possible release of swarms of mosquitoes that, until now, have been locked away in a research lab behind doublemetal doors and guarded 24/7.

The goal: to nearly eradicate the population of one species of mosquito, and with it, the heavy burdenof malaria across Africa.

These scientists are planning to release mosquitoes equipped with gene drives, a technology that overrides natures genetic rules to give every baby mosquito a certain trait that normally only half would acquire. Once such an insect gets out into the wild, it will move indiscriminately and spread its modified trait without respect for political borders.

No living thing no mammal, insect, or plant with a gene drive has ever been set free. But if all goes as planned, it mighthappen here, in a remote village of about a thousand people, where the residents dont even have a word for gene.

Despite such barriers, this is in some ways the most logical place to carry out the experiment. Nowhere does malaria exact a higher toll than here in sub-Saharan Africa, where hundreds of thousands die from the disease every year. And Burkina Faso already houses one of Africashighest-profile malaria research laboratories.

It may be six years before the gene drive mosquitoes are actually released in Burkina Faso, but scientists are already working around the clock to prepare the community for their release. Researchers in Mali and Uganda are also working toward the same goal under the banner of the Target Malaria project, propelled by $70 million from the Bill and Melinda Gates Foundation and support from research laboratories in England and Italy.

Speaking through interpreters, residents across Burkina Faso told STAT that they are grateful for the scientists work, and are eagerly looking forward to eliminating the dreaded disease.

But scientists still face achallenge: making sure that people understand and accept thenewfangled genetic technology behind it all. That means building trust and doing basic education explaining not only the impact of genetically engineered insects arriving in their homes, but also what genetics is in the first place.

Driving west from Bobo-Dioulasso, the sleepy regional capital that is Burkina Fasos second-largest city, the pavement fades away into an undulating dirt path. Traffic dissolves into a trickle of motorbikes whose drivers wear surgical-style masks to protect them from the dust. Donkey carts plod along under the weight of flattened grass, outpacing camels weighed down by saddlebags.

At the height of the dry season in late December, eight scientists and social scientists pulled off the dirt road,carrying a box of a hundred adult mosquitoes and a 1-liter bottle filled with wriggling larvae.

For the past few years, the scientists from the Institut de Recherche en Sciences de la Sante (IRSS) in Bobo-Dioulasso, where the countrys Target Malaria team is based,have been teaching Bana residents basic mosquito facts, including that the bugs transmit malaria. Many in Burkina Faso believe that malaria can be spread by eating too many greasy or sweet foods, said Lea Pare, the anthropologist who is leading a national effort to engage local citizens in Target Malaria.

Beyond live mosquitoes, the team also uses pictures to help explain the complicated scientific information: a set of thirteen cards, laminated like giant placemats, which detail the different phases of the project. In Bana, they talk through the first four of these cards, which show gigantic female mosquitoes biting humans, with small red squiggles flowing through the proboscis and into the persons body. On the fourth card, a scientist wearing a white coat is looking at those mosquitoes under a microscope.

White coats are very familiar to residents of Bana. For the last three years, a team of researchers has lived part-time in the village, sleeping in an old cement house retrofitted into a scientific base camp. These technicians, with the help of local volunteers, count the number of mosquitoes in the homes, observe the mating swarms at dusk, and dust mosquitoes with colored powder to track where they travel around the village.

They are gathering data on the mosquito population to feed into intricate computer models that will help them determine how the gene drive mosquitoes should be released.

When the technicians stepped into one home on a recent day, they laid thick sheets across the floor of a bedroom and filled it with acrid-smelling insecticide spray. After 10 minutes, they hauled the sheets out, opened them up, and crouched over a small pile of dirt specks: only one male mosquito.

For low mosquito season, it wasnt surprising. During the rainy season, however, which starts in June, there might be a few hundred mosquitoes in each room, said technician Ibrahim Diabate.

Men living in the treated homes were excited, even jubilant, that the researchers were working in the village. They understood that the scientists had a longer-term plan to battle the mosquitoes, but they were also happy for the insecticide spray in the present moment.

Since you started this work, praise God, malaria has been reduced, because mosquitoes dont bite us anymore, said Ali Ouattara, one elder in the community.

In the next phase of the project, scientists will have to explain to Ouattara why theyre actually releasing more mosquitoes.

Going straight from zero to gene drives would be too extreme, so scientists are planning to release regular genetically engineered mosquitoes first either here in Bana or in one of two other villages nearby.

Those mosquitoes, which could be released next year, are sterile males: Most of them are male, and they cannot have offspring. A field release is not intended to reduce the prevalence of malaria; rather, it is to prepare the scientists and the locals for the eventual arrival of the gene drive mosquitoes, said Delphine Thizy, who directs the work of engaging local, national, and international leaders for the project.

The outreach teams have started talking about DNA with their flash cards. But they arent saying anything yet to the locals about the much more powerful, and complicated, idea of a gene drive.

Partly thats because researchers didnt want the residents of Burkina Faso to expect that a miracle solution to the malaria epidemic isjust around the corner, Thizy said. Scientists in London havent yet created the gene drive mosquitoes that would be used, and field trials of such mosquitoes are years away.

Also, she said, gene drives are hard to understand.

To be fair, even in Europe and in North America, its complex to understand gene drives in one shot.

If gene drive mosquitoes arrive in Burkina Faso, it will be thanks to the vision of Abdoulaye Diabate, a soft-spoken medical entomologist with a singular mission: to stop malaria.

The disease is ever-present in thiscountry mosquito nets hang for sale by the roadside, and hotel proprietors lay out smoldering coils in the courtyards to ward off mosquitoes as dusk falls.

Diabate, who is deeply involved in malaria eradication efforts worldwide, became dismayed when, in the 1990s, he realized that mosquitoes were building up resistance against the insecticide used on bed nets here.

If this is the only tool we have in hand, then forget about malaria elimination, Diabate said.

But,in 2012, he received an invitation to a meeting about the Target Malaria project, which was focused on solutions involving genetic engineering. He jumped at the chance.

Today he is leading the Burkina Faso team, trying to get the whole world from remote villages to international diplomats on board with his ambitious research.

Meanwhile, thousands of miles away in the United Kingdom, geneticists at Imperial College London are working on designing the gene drive mosquitoes. Specifically, theyre studying two different ways to disrupt the reproductive system of one particular species, Anopheles gambiae: reduce the number of female babies (only females bite and spread the disease) or stop the mosquitoes from having offspring in general.

To make the population predominantly male, Austin Burt, Target Malarias primary investigator, and collaborators are studying an X shredder a gene that destroys the X chromosome in sperm, making all offspring males. Alongside that, theyre looking at reducing the number of mosquitoes of both sexes by creating genes that make them sterile.

Either approach might lead to massive population collapse within two to eight years, according to Charles Godfray, a University of Oxford professor and biologist who works on modeling for the Target Malaria project.

But the insects wouldnt go extinct, scientists say. The gene drive mosquitoes currently under consideration would only reduce the population of Anopheles gambiae enough to stop the transmission of malaria.

The foundation is not interested in eliminating Anopheles mosquitoes, said Dr. Scott Miller, who leads malaria research and development for the Gates Foundation. Were interested in eliminating malaria.

It will take years to reach the point that scientists will be ready to test the gene drive mosquitoes in the wild. In the meantime, they are facing the challenge of winning over local residents who might be wary of these new creatures.

Mariam Pare was initially frightened. A commanding woman who teaches in a Koranic school, Pare livesacross the street from the IRSS in Bobo-Dioulasso. Shesaid that when she first heard about mosquito research going on at the lab, she feared that the scientists were breeding mosquitoes to let loose on the locals. But after meetings and discussions with project staff, she came to understand that theyare instead trying to fight against the mosquito.

She even took a tour of the insectary that currently holds the gene-edited sterile male mosquitoes, and could eventually hold the gene drive ones. She saw fans that would suck away mosquitoes if they happened to escape from their cages, and a hot water bath where unnecessary mosquitoes go to die.

Because I saw what was going on in there, I believe and trust the people that work in there, she said.

Earning Pares trust was particularly important for the team because she lives so close to the insectary, her consent was required to import the sterile male mosquitoes. That requirement isnt a legal one, but one that the Target Malaria project has put in place. The Gates Foundation has also said that gene drive mosquitoes will only be released if the host country agrees.

Lassina Diarra, a tailor whose turquoise-walled shop is down the road from the research lab, also had to give his consent. Sitting on the corner of a table among scraps of fabric and hand-tailored suits, he said that he was impressed by the scientists transparency and reliability. Two outreach workers recruited him to serve on a group of 12 local leaders who communicateinformation about the project to the citys residents, dubbed the relay group, along with a different committee to address community grievances. Every few weeks, he knocks on doors up and down the streets, updating his neighbors on the scientists progress.

In June, Diarra and Pare both signed off on the arrival of the sterile males. So did Kadidia Ouattara, one of the relay group members and the president of multiple neighborhood associations. She recalled a joyous gathering filled with dance and song.

Ni fonyon douma ni bora mi? they sang in Dioula. Ni fonyon douma ni bora mi?

The song translates to, Where did this good air come from? and, more colloquially, means, This is too good to be true!

Ouattara said that it is a traditional song commemorating good news a wedding, the birth of a baby, the success of a student in her exams. And on that day, it was celebrating the impending arrival of genetically modified mosquitoes.

Burkina Faso has experience with genetically modified organisms. One of the first associations some residents make with genetic engineering is Monsanto, which has been selling genetically modified cotton seeds to Burkinabe farmers since the 2000s. But the countrys growers association stopped buying the seeds in 2016 in the wake of concerns about the cottons quality and country-wide protests against the company.

One resident of Bobo-Dioulasso complained that genetically modified food rots quickly, and said that he hopes the mosquitoes suffer the same fate: an early death.

The fight against malaria is a big concern, but the solutions are sometimes scary, said Sylvestre Tiemtore, the director of an organization that represents over half of the nongovernmental organizations in Burkina Faso. The group met with Target Malaria in July, a discussion which was very heated, he said.

In movies he cited Jurassic Park weve seen some research that went out of control, he said.

Scientists familiar withthe effort here say defining the idea of genetically modified to residents here might be of limited use, because it wont help people understand what the mosquitoes are or what they will really do, said Javier Lezaun, deputy director of the Institute for Science, Innovation, and Society at the University of Oxford, who is not involved in the Target Malaria project. In fact, the phrase might just serve to distract and scare he spoke of another community in Tanzania who thought that a swarm of mosquitoes that invaded a hospital were genetically modified (they werent), and of others in Brazil who thought that Zika arrived as a result of genetically modified mosquitoes (it didnt).

As long as you explain something about the specific capabilities of the mosquitoes, or the limitations of these particular mosquitoes and how theyre supposed to behave in the wild or in the facilities, I think that serves the purpose of explaining genetic modification, Lezaun said.

And thats what many people are curious about. At the July meeting with NGOs, hosted by the Secrtariat Permanent des Organisations Non Gouvernementales (SPONG for short), attendees wanted to know: What would happen to the local ecosystem? And might these engineered mosquitoes be able to transmit other diseases?

Some of these questions dont yethave answers, but others do. A risk assessment commissionedby the Foundation for the National Institutes of Health, a US nonprofit that supports the federal agency, found that the risk of the sterile mosquitoes currently in Bobo-Dioulasso transmitting other diseases was incredibly low; the modified mosquitoes probably wont spread more malaria than their wild cousins; and the genetic modification probably wont spread from the mosquito to other animals.

Outside scientists, convened by the FNIH in May, had previously concluded that Anopheles gambiae is not a keystone species, meaning that if its population shrank dramatically, the ecosystem would not be substantially impacted.

But the meetings continue. Tiemtore, SPONGs director, said that he would like to have a meeting with representatives of different health-related NGOs that are based in Burkina Fasos 13 different regions, to educate them about the project. But that requires money to bring them to the capital, and to cover the costs of the meeting itself.

They might need to rent a room, Tiemtore said. They might need to offer some coffee breaks. That costs money. Who pays for that? If you dont do all of those things, your mosquitoes are going to come out, but they wont be released in the regions, because the people will not agree with it, because they didnt have enough information on it, and they will have the right to be afraid.

The development of powerful new genetic engineering technologies, often outstripping regulators ability to keep up, is forcing scientists to reckon with the ethics of their work in a new way.

Of course, humans have been making potentially irreversible changes to our environment for a long time: clearing forests for farming, building power plants that change the composition of the atmosphere, and producing untold tons of synthetic materials like plastic that will stay in the environment for hundreds of years.

But gene drives lend these questions a different sort of urgency. The genetic technology can quickly change the properties of an entire population of a species, undoing millennia of evolution in a handful of years. And once you let them out of the cage, theres no going back other world-altering technologies have not been self-perpetuating like gene drive animals would be.

So scientists are treading carefully and doing what they can to keep the rest of the world involved. This has led to difficult questions: Who needs to give them permission to do certain things? What does it mean for residents to be fully informed? In answering them, there arent a lot of models to follow. There are only a fewgene drive projects underway in the world, and none has yet resulted in the release of the animalsinto the wild.

Academic research on how to effectively include non-scientists in global healthdecisions is also lacking, said Jim Lavery, an Emory University professor of global health and ethics who has worked with the Target Malaria project in the past.

Right now, Lavery said, scientists can count the number of phone calls they make and the number of people who show up at community meetings, but we dont even have an understanding at a proxy level of what those things are supposed to represent in terms of effectiveness of engagement.

While researchers like Lavery are trying to determine how to measure success, research is plowing ahead. Some scientists are thinking about releasing gene drive mice halfway across the world, in New Zealand, to eliminate invasive species. AndKevin Esvelt, a gene drive guru based at the Massachusetts Institute of Technology, is flying to Argentina in September to talk about using gene drives to get rid of flesh-eating flies.

He has said that gene drives are more important as a societal tool to change the way that science is done it should be open to and inclusive of the people it will impact. To that extent, he praised Target Malarias community work. I honestly dont see how you could do it any other way, he said, citing the language and cultural barriers that the project is working to overcome.

How the project is going to introduce gene drive mosquitoes, though, is an open question. National regulators and international organizations like the World Health Organization are still working on developing guidelines for introducinggenedrive animals.

And in Burkina Faso, Thizy said she hasnt even yet put a lot of thought into what it will mean for local leaders to understand a release of gene drive mosquitoes. She said it will probably include knowing that the modified mosquitoes will stay in the environment and grow in number, until some point at which the population of Anopheles gambiae will be reduced.

But, said Thizy, exactly how the gene drive works may matter less to the people than the impact it will have on them and their lives.

She pointed, by way of analogy, to her previous work as a consultant for a mining company in the Ivory Coast: It wasnt how big is the hole, how many holes, and how does the machine work that the area residents were worried about, she said, but rather how they would be compensated and what jobs would be created.

On a dusty Wednesday morning earlier this year, Kadidia Ouattara arrived at an outdoor market, eager to chat with the vendors about genetically engineered mosquitoes.

As a woman spooned tomato sauce from a gigantic aluminum can onto plastic sheets for individual sale, Ouattara told her about the insect lab just a few minutes walk down the street.

The researchers who work there are trying to reduce the population of mosquitoes, she said. Dont be afraid I saw the inside of the lab and all of the research. There are public meetings where they explain what they are doing, and if there is another one, I will let everybody know.

The woman was delighted. May God help the project be a success, she said.

Farther along, she came upon a butcher who she knew to be particularly recalcitrant. He thinks were getting money from the white people, Ouattara said. But thats not true shes a volunteer.

Ouattara walked up to the man, who was hacking at a piece of meat with a foot-long knife, bits of gristle flying everywhere and flies swarming. Rivulets of blood ran along the dusty ground.

If there is a meeting about the project, I am begging you to come, she said.

Scarcely taking his eyes off of the meat, the butcher mumbled some kind of assent.

Ouattaras enthusiasm was undimmed; she strode off to a woman selling onions. And shed be back soon with more news to share.

Eric Boodman and Kate Sheridan contributed reporting.

Special thanks to Housmane Sereme and Steve Sanou for translation services.

Republished with permission fromSTAT. This articleoriginally appearedon March 14, 2017

See original here:
A Revolutionary Genetic Experiment is Planned for a West African Village If Residents Agree - Scientific American

4 Ways for Agencies to Sell Clients on Behavioral Marketing Programs – Medical Marketing and Media

March 13, 2017

Luke Perez, VP, account planning and strategy, AbelsonTaylor

The truth is that we lie to ourselves and we lie even more flagrantly to market researchers. A mom may say that she feeds her kids organic and free-range food, but there's almost always a stash of Oreo cookies somewhere. We need to study our audiences' behaviors, and their corresponding motivations, to unearth the truth behind the decisions they make. Not to sound trite, but actions speak louder than words. If we really want to know what could drive an HCP or patient to utilize our brand, or to remain adherent, we need to understand how their behaviors impact choice and utilization.

Kathleen Starr, managing director, Adheris Health Behavioral Insights, an inVentiv Health company

Most of the industry acknowledges that patient behavior impacts brand performance. But quantifying this using transactional data can give clients a better appreciation of the need to move beyond awareness promotion. Evidence is also needed to tackle the daunting task of changing patient behavior. To date, there are more than 100 scientifically proven behavior-change techniques. However, choosing and applying them in ways that will improve brand performance requires scientific expertise and insights into the psychosocial context of patient behavior. The science alone won't cut it we need creativity to bring it to life. So we then architect, design, and brand programs that pull the science though into experiences that entice the level of patient engagement needed for behavior change. Only then are we able to provide evidence back to clients that it is time and money well spent.

D'Arcy King, EVP and chief strategy officer, Daggerwing Health

Evidence, evidence, evidence. Over the past decade, behavioral scientists have worked to link behavioral theory to behavior-change techniques (BCT). Identifying and providing proof that the processes, or the how behind behavioral change interventions, actually affect health behavior and provide ROI is critical to their advancement and adoption. Agencies and clients would benefit from adopting evidence-based BCTs and integrating them with human-centric design to provide interventions and programs that drive business results, improve quality of life, and create a trusted relationship with their brand.

Jessica Brueggeman, EVP, health behavior group, MicroMass Communications

Agencies should provide clients with the ability to promote behavioral science's benefits. They need to present a well thought-out story that demonstrates the evidence, connects to commercial objectives, and provides tangible application examples. Agencies must create opportunities that help clients build skills in applying behavioral science strategies. When clients possess such foundational skills, they can better articulate how these strategies can accelerate brand objectives. They also understand how behaviorally based strategies can be leveraged across brand initiatives and why they are preferred over traditional, information-based approaches.

Read this article:
4 Ways for Agencies to Sell Clients on Behavioral Marketing Programs - Medical Marketing and Media

Let's Make American Medicine Great Again – Anti Aging News

A4M has for the past 25 years shown the ability through vision and technology to make American medical care great once again. The time has come for a major overhaul of the American healthcare system. "While Obamacare had some noble intentions, Obamacare and politicians have driven medicine into a constant state of disarray. Its time for medical leaders such as the A4M to voice their opinion," asserts Dr. Ronald Klatz.

Dr. Ronald Klatz, M.D., D.O., physician-founder of the American Academy of Ant-Aging Medicine and patent holder of over 30 medical innovations stated, "Physicians must resume control of patient care. Today the insurance company rep has more influence than a doctor. Thats a sad statement. It is necessary to have a plan that restores authority to highly experienced, regulated and educated medical professionals. We should focus on effective, preventative healthcare to extend quality of life and increase longevity, and simply bring back common sense to medicine."

The following 10-point, low-cost, high-tech healthcare, wellness, and anti-aging plan has the potential to save American tax payers over one trillion dollars over the next seven years:

Point One: Point of Care (POC) Laboratory Testing. Defined as testing at/near the site of patient care. The goal of POCT is to allow more rapid and effective diagnosis and triage, leading to improved patient outcomes, reduced morbidity and mortality, and slashed costs.

Point Two: Biomarkers of Aging and Health Measurement. Billions of health care dollars are wasted on diseases that can be detected and treated early or prior to occurrence: heart disease and stroke, cancer, and Type 2 diabetes.

Point Three: Free Biannual Comprehensive Metabolic Testing. These tests may slash Type 2 diabetes and metabolic syndrome costs by 20%. This is significant given that Metabolic Syndrome is a primary cause of cardiovascular disease (CVD).

Point Four: 24/7 Telemedicine Consultation Access. The improvements generated from the use of telemedicine are vast. Telemedicine provides access to medical professionals for residents of remote areas and people with limited mobility, unclogs emergency rooms from non-emergency patients, and creates jobs for people who are only able to work via telecommuting.

Point Five: Aging Intervention Drugs. Six major diseases are having an enormous impact on the 65+ population: chronic lung disease, ischemic heart disease, stroke, lung cancer, pneumonia, and gastrointestinal illness.

Point Six: Stem Cells and Nanotechnology Access. These biomedical technologies offer exciting potential for significant improvement and/or cures for previously incurable conditions, such as stroke, cancers, Alzheimer's disease, Parkinson's disease, ALS, paraplegia, and other crippling neuromuscular disorders.

Point Seven: Personalized Genetic Testing and Nutrigenomics. Making these resources widely accessible allows for prospective identification of major disease processes including heart disease, cancer, diabetes, Alzheimer's disease, etc., such that appropriate interventions may be deployed at the earliest stage possible, providing the best chance for recovery and less invasive and more cost-effective treatment options.

Point Eight: Free/Subsidized Access to Gym, Spa, Metabolic Detoxification, and Physical Rehabilitation Facilities. Without question, obesity is costing the United States billions upon billions of dollars to combat all of its resulting diseases and conditions.

Point Nine: Online Electronic Database on Aging Intervention & Free Medical Education Resources. By promoting practitioner and patient education, an improved paradigm is created in which physicians keep current on new technologies and patients questions and form a collaborative relationship with their medical caretakers. This increased education on both sides of the healthcare relationship will provide more accountability and communication.

Point Ten: World Center for Anti-Aging Medicine. A center of excellence to extend quality of life into the later years of the average lifespan is necessary for reducing costs and improving living. One centralized research facility dedicated to this specific mission is necessary to focus adequate attention on this vital scientific arena.

While prior administrations have failed to properly consider the value of shifting from a "disease based" healthcare model to an advanced preventative based, cost-saving platform, the new administration has an opportunity to change course. Elected leadership should implement this comprehensive plan immediately to reduce skyrocketing costs and improve the quality of all our lives. The new Health and Human Services (HHS) administration must help Americans get true, proven preventative care and encourage healthier lifestyles. This is the time for real solutions.

As Dr. Klatz states, "We already have the technology to live a quality, healthy, productive, youthful 100 years- plus. Now lets do it!" Please forward to your representative in Washington.

Read more:
Let's Make American Medicine Great Again - Anti Aging News

Health Benefits of Lion's Mane Mushroom – Anti Aging News

Health Benefits of Lion's Mane Mushroom

The Chinese have used Lions Mane Mushroom as a medicine for centuries. Many communities in Asia have used it as food. The Chinese and Japanese call it hou tou gu and yamabushitake respectively. It derives its name from a distinctive appearance that makes it resemble the mane of a shaggy lion. Apart from its appearance, origins, use as food and local names, the Lions Mane Mushroom has several health benefits too.

Boosts Digestive Health

The plant proved highly useful in promoting digestive health. It enables the stomach and liver to function properly. It also protects the liver. It is effective at treating chronic gastric inflammation, duodenal ulcers, and peptic ulcers. Many patients have used it in alleviating mental apathy (also known as neurasthenia). Its usage as a restorative health tonic has also borne good fruits.

Useful as a Dietary Supplement

Today, the mushroom continues to prove its efficiency in clinical use. Physicians recommend it as a dietary supplement. The reason for this is the positive effect that it has on mood, brain health, and memory. Scientific studies have proved that the mushroom is capable of increasing neurotrophic activities. It stimulates the growth of nerve or brain cells, thus boosting neurotrophic activities. This effect enhances its reputation as a brain strengthener and antidepressant. Facilitates the Production of Nerve Growth Factor

The mushroom has bioactives, which are called hericenones (or aromatic molecules). These bioactives, including erinacines (or diterpene compounds), collaborate to boost the production of Nerve Growth Factor (NGF) in nerve cells. By doing this, the mushroom maintains forebrain function and cholinergic system. So, the mushroom plays a role in the proper maintenance of the central nervous system. Remember, the forebrain is important because of the following:

Reduces Bad Cholesterol and Increases Good Cholesterol

Other than medicinal uses, Lions Mane Mushroom is also renowned as a cholesterol reducer. A unique, submerged culture of the mushroom reduces cholesterol by around 32%. The same culture reduces LDL cholesterol by around 45.4%. It also reduces triglycerides by as much as 34.3 percent. More importantly, it increases HDL cholesterol, which is the good cholesterol, by around 31%. So, it eradicates the bad while boosting the good cholesterol.

Provides Perfect Immune Support

Additionally, it offers immune support. It increases the ability of the host (whether animals or humans) to resist infection. The mushroom enhances the uptake of bacteria by white blood cells. The immune booster increases the ability of macrophage cells to engulf the harmful bacteria before destroying them. Treating cell culture with an extract of Lions Mane Mushroom allows the cells to display greater movement against the bacteria rather than controlling them. The other health benefits of Lions Mane Mushroom include:

Theres little doubt about the effectiveness of the mushroom extract. Its health benefits make it one of the most exciting nutraceuticals. It has been tested on humans and found effective at enhancing memory and improving moods. However, most of its health benefits have so far been displayed in animals and test tube results. The mushroom needs to undergo further testing on humans its precise efficacy levels and the recommended dosages.

See the original post:
Health Benefits of Lion's Mane Mushroom - Anti Aging News

Doctor in St. Louis County who prescribed illegal HGH can practice … – STLtoday.com

ST. LOUIS A St. Louis County doctor who pleaded guilty last year to a federal felony, and admitted he illegally sold misbranded human growth hormone to patients, is licensed to practice medicine again.

Dr. Michael Ted Mimlitz, 51, was sentenced in April 2016 to two years of probation and fined $30,000 for selling misbranded human growth hormone to local clinic patients, prosecutors said. He also had to forfeit $59,500, representing some of the proceeds from the sale of the drug.

Mimlitz went just 3 months without a medical license. The Missouri Board of Registration for the Healing Arts revoked his medical license in November. But he had already applied for a new license in October. The board granted a new license on March 2.

The license is on probation for two years. Within the first six months, he must successfully complete board-approved courses in ethics and prescribing. He could not be reached for comment.

Mimlitz admitted in U.S. District Court that he become involved in the Mens Medical Institute after identifying a need for a clinic specializing in testosterone replacement therapy for men.

Patients began asking for human growth hormone, he said, and he found a Mexican supplier online after being unable to find it in the U.S. He sold the misbranded drugs to about 40 patients.

The drugs were misbranded, contained labels in Spanish, not English, and were not manufactured by a facility licensed or registered by the U.S. Food and Drug Administration, according to court testimony.

Prosecutors pointed out in a statement announcing the plea that doctors can prescribe HGH for a handful of reasons, including wasting diseases associated with AIDS or Prader-Willi syndrome, but not to help patients with body-building, anti-aging, or weight loss treatments.

Original post:
Doctor in St. Louis County who prescribed illegal HGH can practice ... - STLtoday.com